Sanofi & Regeneron’s Dupixent pivotal study meets all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis: Paris Monday, November 10, ...
Vodafone Idea, Oil and Natural Gas Corporation, SJVN, Rail Vikas Nigam, Bharat Forge, Hindustan Aeronautics, IRCTC - Indian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback